Literature DB >> 12200433

Activated pp60c-Src leads to elevated hypoxia-inducible factor (HIF)-1alpha expression under normoxia.

Rotem Karni1, Yuval Dor, Eli Keshet, Oded Meyuhas, Alexander Levitzki.   

Abstract

Hypoxia-inducible factor (HIF)-1 is a master transcription factor, which up-regulates glycolysis, erythropoiesis, and angiogenesis under hypoxia. HIF-1alpha accumulates in normoxic tumor cells, leading to glycolysis under aerobic conditions. This phenomenon, known as the "Warburg effect," is caused by a yet unknown mechanism. Here we show that transformed cells that express constitutively active pp60(c-Src) (Src) express HIF-1alpha protein under normoxia, which results in the expression of multiple HIF-1alpha target genes. We show that this occurrence is due to an enhanced rate of HIF-1alpha protein synthesis and not due to reduced HIF-1alpha degradation. Furthermore, we show that the Src-induced increase in protein synthesis is due to the global increase in the rate of cap-dependent translation and does not involve inhibition of HIF-1alpha degradation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12200433     DOI: 10.1074/jbc.M206141200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

1.  Hypoxia-inducible factor-1alpha and the glycolytic phenotype in tumors.

Authors:  Ian F Robey; Anthony D Lien; Sarah J Welsh; Brenda K Baggett; Robert J Gillies
Journal:  Neoplasia       Date:  2005-04       Impact factor: 5.715

2.  Lysophosphatidic acid stimulates epithelial to mesenchymal transition marker Slug/Snail2 in ovarian cancer cells via Gαi2, Src, and HIF1α signaling nexus.

Authors:  Ji Hee Ha; Jeremy D Ward; Rangasudhagar Radhakrishnan; Muralidharan Jayaraman; Yong Sang Song; Danny N Dhanasekaran
Journal:  Oncotarget       Date:  2016-06-21

3.  Up-regulation of AMP-activated protein kinase in cancer cell lines is mediated through c-Src activation.

Authors:  Sarit Mizrachy-Schwartz; Noam Cohen; Shoshana Klein; Nataly Kravchenko-Balasha; Alexander Levitzki
Journal:  J Biol Chem       Date:  2011-01-18       Impact factor: 5.157

4.  The Molecular Mechanisms that Promote Edema After Intracerebral Hemorrhage.

Authors:  Daniel Bodmer; Kerry A Vaughan; Brad E Zacharia; Zachary L Hickman; E Sander Connolly
Journal:  Transl Stroke Res       Date:  2012-04-12       Impact factor: 6.829

5.  Src Inhibition Blocks c-Myc Translation and Glucose Metabolism to Prevent the Development of Breast Cancer.

Authors:  Shalini Jain; Xiao Wang; Chia-Chi Chang; Catherine Ibarra-Drendall; Hai Wang; Qingling Zhang; Samuel W Brady; Ping Li; Hong Zhao; Jessica Dobbs; Matt Kyrish; Tomasz S Tkaczyk; Adrian Ambrose; Christopher Sistrunk; Banu K Arun; Rebecca Richards-Kortum; Wei Jia; Victoria L Seewaldt; Dihua Yu
Journal:  Cancer Res       Date:  2015-09-17       Impact factor: 12.701

6.  Activation of hypoxia-inducible factor 1 in human T-cell leukaemia virus type 1-infected cell lines and primary adult T-cell leukaemia cells.

Authors:  Mariko Tomita; Gregg L Semenza; Canine Michiels; Takehiro Matsuda; Jun-Nosuke Uchihara; Taeko Okudaira; Yuetsu Tanaka; Naoya Taira; Kazuiku Ohshiro; Naoki Mori
Journal:  Biochem J       Date:  2007-09-01       Impact factor: 3.857

Review 7.  Role of nitric oxide in the maintenance of pluripotency and regulation of the hypoxia response in stem cells.

Authors:  Amparo Beltran-Povea; Estefania Caballano-Infantes; Carmen Salguero-Aranda; Franz Martín; Bernat Soria; Francisco J Bedoya; Juan R Tejedo; Gladys M Cahuana
Journal:  World J Stem Cells       Date:  2015-04-26       Impact factor: 5.326

8.  Identification of pY654-β-catenin as a critical co-factor in hypoxia-inducible factor-1α signaling and tumor responses to hypoxia.

Authors:  Y Xi; Y Wei; B Sennino; A Ulsamer; I Kwan; A N Brumwell; K Tan; M K Aghi; D M McDonald; D M Jablons; H A Chapman
Journal:  Oncogene       Date:  2012-12-17       Impact factor: 9.867

9.  Tumor suppressive protein gene associated with retinoid-interferon-induced mortality (GRIM)-19 inhibits src-induced oncogenic transformation at multiple levels.

Authors:  Sudhakar Kalakonda; Shreeram C Nallar; Ping Gong; Daniel J Lindner; Simeon E Goldblum; Sekhar P Reddy; Dhananjaya V Kalvakolanu
Journal:  Am J Pathol       Date:  2007-09-06       Impact factor: 4.307

10.  Oncogenic KRAS modulates mitochondrial metabolism in human colon cancer cells by inducing HIF-1α and HIF-2α target genes.

Authors:  Sang Y Chun; Craig Johnson; Joseph G Washburn; Marcia R Cruz-Correa; Duyen T Dang; Long H Dang
Journal:  Mol Cancer       Date:  2010-11-13       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.